FANCM branchpoint translocase: Master of traverse, reverse and adverse DNA repair

L Abbouche, R Bythell-Douglas, AJ Deans - DNA repair, 2024 - Elsevier
FANCM is a multifunctional DNA repair enzyme that acts as a sensor and coordinator of
replication stress responses, especially interstrand crosslink (ICL) repair mediated by the …

[HTML][HTML] The FANC/BRCA pathway releases replication blockades by eliminating DNA interstrand cross-links

X Renaudin, F Rosselli - Genes, 2020 - mdpi.com
DNA interstrand cross-links (ICLs) represent a major barrier blocking DNA replication fork
progression. ICL accumulation results in growth arrest and cell death—particularly in cell …

[HTML][HTML] Novel Bi-Allelic Variants of FANCM Cause Sertoli Cell-Only Syndrome and Non-Obstructive Azoospermia

Y Zhang, P Li, N Liu, T Jing, Z Ji, C Yang, L Zhao… - Frontiers in …, 2021 - frontiersin.org
Non-obstructive azoospermia (NOA) is the most severe disease in male infertility, but the
genetic causes for the majority of NOA remain unknown. FANCM is a member of Fanconi …

[HTML][HTML] The FANCM: p. Arg658* truncating variant is associated with risk of triple-negative breast cancer

G Figlioli, M Bogliolo, I Catucci, L Caleca… - NPJ breast …, 2019 - nature.com
Breast cancer is a common disease partially caused by genetic risk factors. Germline
pathogenic variants in DNA repair genes BRCA1, BRCA2, PALB2, ATM, and CHEK2 are …

[HTML][HTML] Pathogenic mutations identified by a multimodality approach in 117 Japanese Fanconi anemia patients

M Mori, A Hira, K Yoshida, H Muramatsu, Y Okuno… - …, 2019 - ncbi.nlm.nih.gov
Fanconi anemia is a rare recessive disease characterized by multiple congenital
abnormalities, progressive bone marrow failure, and a predisposition to malignancies. It …

A tumor suppressive DNA translocase named FANCM

J Basbous, A Constantinou - Critical Reviews in Biochemistry and …, 2019 - Taylor & Francis
FANCM is named after Fanconi anemia (FA) complement group M. The clinical symptoms of
FA include congenital abnormalities, pancytopenia, and cancer proneness. However, recent …

[HTML][HTML] Utility of clinical comprehensive genomic characterization for diagnostic categorization in patients presenting with hypocellular bone marrow failure …

P Blombery, LC Fox, GL Ryland, ER Thompson… - …, 2021 - ncbi.nlm.nih.gov
Bone marrow failure (BMF) related to hypoplasia of hematopoietic elements in the bone
marrow is a heterogeneous clinical entity with a broad differential diagnosis including both …

[HTML][HTML] ALTernative functions for human FANCM at telomeres

B Domingues-Silva, B Silva, CM Azzalin - Frontiers in Molecular …, 2019 - frontiersin.org
The human FANCM ATPase/translocase is involved in various cellular pathways including
DNA damage repair, replication fork remodeling and R-loop resolution. Recently, reports …

The Fanconi anemia pathway and Breast Cancer: A comprehensive review of clinical data

P Gianni, E Matenoglou, G Geropoulos, N Agrawal… - Clinical Breast …, 2022 - Elsevier
The development of breast cancer depends on several risk factors, including environmental,
lifestyle and genetic factors. Despite the evolution of DNA sequencing techniques and …

[HTML][HTML] FANCA deficiency promotes leukaemic progression by allowing the emergence of cells carrying oncogenic driver mutations

P Pawlikowska, L Delestré, S Gregoricchio, A Oppezzo… - Oncogene, 2023 - nature.com
Leukaemia is caused by the clonal evolution of a cell that accumulates mutations/genomic
rearrangements, allowing unrestrained cell growth. However, recent identification of …